Internal Medicine, Medical Oncology · Baltimore, MD
NPI
1952811044
Since 2017
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1800 Orleans Street
Baltimore, MD, 21264
Phone (410) 502-2037
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
690 services
Medicare patients, 2024
144
Average age 72
Drug cost, 2024
$3.3M
324 prescriptions
Company payments, 2025
$9,864
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yasser Ged was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 212 times for 92 patients. In total Yasser Ged billed 690 services in 15 codes, and Medicare paid $49K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 212 | 92 | $13.41 | $2,843 |
| 99215 Office E&M - Established | Facility | 160 | 71 | $112.98 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 76 | 23 | $95.88 | $7,287 |
| 99214 Office E&M - Established | Facility | 64 | 46 | $73.26 | $4,689 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 28 | $13.41 | $617 |
| 99205 Office E&M - New | Facility | 40 | 40 | $146.28 | $5,851 |
| 99214 Office E&M - Established | Office | 29 | 19 | $103.13 | $2,991 |
| 99215 Office E&M - Established | Office | 23 | 17 | $149.46 | $3,438 |
By year: 2022 $39K for 435 services; 2023 $49K for 439 services; 2024 $49K for 690 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yasser Ged prescribed most often to Medicare patients was Cabometyx (Cabozantinib S-Malate), with 53 prescriptions and refills. In total Yasser Ged wrote 324 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabometyx Cabozantinib S-Malate | 53 | 53 | Under 11 | $1.2M |
| Eliquis Apixaban | 33 | 34 | Under 11 | $17K |
| Lenvima Lenvatinib Mesylate | 28 | 28 | Under 11 | $635K |
| Welireg Belzutifan | 24 | 24 | Under 11 | $724K |
| Levothyroxine Sodium Generic | 20 | 31 | Under 11 | $137 |
| Inlyta Axitinib | 19 | 19 | Under 11 | $381K |
| Prochlorperazine Maleate Generic | 16 | 16 | 11 | $146 |
Brand drugs: 170 claims; generic drugs: 154 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yasser Ged $9,864 ($8,052 in general payments such as food, travel and fees and $1,813 for research) from 6 companies. The largest payer was Exelixis Inc. with $4,198.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.